Pharmaceutical Industry Trends & News - Pharmaceutical Technology

Features

Non-viral gene therapies emerge as key players amid viral safety bottlenecks

Non-viral gene therapies may ease some safety, pricing and manufacturing challenges linked to viral vectors, but experts say both approaches will still have a place.

Annabel Kartal Allen

News

UCB doubles down on TCEs with $2.2bn Candid buyout

Annabel Kartal Allen

News

Novo Nordisk to launch Ozempic for type 2 diabetes in US

Salong Debbarma

News

Axsome receives FDA approval for Auvelity to treat Alzheimer’s agitation

News

Latus Bio secures $97m in funding to boost gene therapy access

News

Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara

Partner Content

How Saudi Arabia is developing as a Middle East hub for clinical trials

News

Arrowhead’s Redemplo secures Australian TGA approval for FCS therapy

Analysis

Analyst Comment

Thinning revenues: inside the $14bn Eliquis patent cliff

GlobalData Healthcare

Features

EU’s Joint Clinical Assessment system still finding its footing

Jam Bensilum

Analyst Comment

Early detection of bowel Cancer in the UK represents success of screening program

GlobalData Healthcare

Analyst Comment

Pharma Meets AI Conference 2026: AI in pharma begins delivering measurable ROI

GlobalData Healthcare

Themes

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Strong systems that enable trust and governance are key to enabling the growth of AI technologies in drug development.

More themes

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Conference Highlights

$3750.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

UCB doubles down on TCEs with $2.2bn Candid buyout

Novo Nordisk to launch Ozempic for type 2 diabetes in US

Axsome receives FDA approval for Auvelity to treat Alzheimer’s agitation

Latus Bio secures $97m in funding to boost gene therapy access

Lannett, Lanexa Biologics and Sunshine Lake secure FDA approval for Langlara

How Saudi Arabia is developing as a Middle East hub for clinical trials

Arrowhead’s Redemplo secures Australian TGA approval for FCS therapy

Thinning revenues: inside the $14bn Eliquis patent cliff

EU’s Joint Clinical Assessment system still finding its footing

Early detection of bowel Cancer in the UK represents success of screening program

Pharma Meets AI Conference 2026: AI in pharma begins delivering measurable ROI

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Conference Highlights

Asthma: Global Clinical Trials Review, 2026

Rheumatic Disorders: Global Clinical Trials Review, 2026

Alzheimer's Disease: Global Clinical Trials Review, 2026

Amyotrophic Lateral Sclerosis: Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026: Conference Highlights

Asthma: Global Clinical Trials Review, 2026

Rheumatic Disorders: Global Clinical Trials Review, 2026

Alzheimer's Disease: Global Clinical Trials Review, 2026

Amyotrophic Lateral Sclerosis: Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing